These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9867530)

  • 1. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
    Schaefer JR; Herzum M; Maisch B
    N Engl J Med; 1998 Nov; 339(22):1641-2. PubMed ID: 9867530
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
    Tybjaerg-Hansen A; Steffensen R; Meinertz H; Schnohr P; Nordestgaard BG
    N Engl J Med; 1998 May; 338(22):1577-84. PubMed ID: 9603795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
    Gaffney D; Pullinger C; Kane J
    N Engl J Med; 1998 Nov; 339(22):1640-1; author reply 1641-2. PubMed ID: 9867529
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial hypercholesterolemia and coronary heart disease: a HuGE association review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):421-9. PubMed ID: 15321838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis in 46 German families with familial hypercholesterolemia: identification of 8 new mutations. Mutations in brief no. 226. Online.
    Ebhardt M; Schmidt H; Doerk T; Tietge U; Haas R; Manns MP; Schmidtke J; Stuhrmann M
    Hum Mutat; 1999; 13(3):257. PubMed ID: 10090484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
    Tybjaerg-Hansen A; Jensen HK; Benn M; Steffensen R; Jensen G; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):211-5. PubMed ID: 15528480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apolipoprotein E polymorphism, hyperlipidemia and risk of myocardial infarct].
    Assmann G; Lenzen HJ
    Internist (Berl); 1985 Nov; 26(11):692-700. PubMed ID: 3908375
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial defective apolipoprotein B-100 (R3500Q) in Northern Ireland.
    McClean E; Graham CA; Ward AJ; Young IS; Martin S; Nicholls DP
    Br J Biomed Sci; 1999; 56(4):258-62. PubMed ID: 10795369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial defect of apo B-100 in subjects with clinically diagnosed primary hypercholesterolemia: identification of the first family with this disorder in Spain].
    Real JT; Chaves JF; Ascaso JF; Armengod ME; Carmena R
    Med Clin (Barc); 1999 Jun; 113(1):15-7. PubMed ID: 10422071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of polymorphism of the 5'-terminal region of apolipoprotein B gene in patients with ischemic heard disease].
    Shadrina MI; Slonimskiĭ PA; Oganov RG; Perova NV; Limborskaia SA
    Genetika; 1996 Aug; 32(8):1041-4. PubMed ID: 8964475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New knowledge of the pathogenesis of familial hypercholesterolemia].
    Beisiegel U; Weber W
    Verh Dtsch Ges Inn Med; 1986; 92():383-9. PubMed ID: 2949446
    [No Abstract]   [Full Text] [Related]  

  • 13. [Application of DNA analysis for differential diagnosis of familial hypercholesterolemia and familial defect of apolipoprotein b-100].
    Krapivner SR; Malyshev PP; Rozhkova TA; Potaraus AB; Kukharchuk VV; Bochkov VN
    Ter Arkh; 2000; 72(4):9-12. PubMed ID: 10833789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Direct detection of mutations in the LDL receptor gene in patients with familial hypercholesterolemia].
    Freiberger T; Kuhrová V; Kozák L; Soska V; Pekarík V; Mĕrínská L; Fajkusová L; Francová H
    Cas Lek Cesk; 1998 Dec; 137(24):750-2. PubMed ID: 10081189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apolipoprotein genes in patients with ischemic heart disease].
    Baĭtasova NB; Rysmendiev AZh; Shchuratova SG
    Klin Med (Mosk); 2001; 79(12):19-21. PubMed ID: 11840804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-mortem investigation of young deceased individuals with ischemic heart disease-outcome of supplementary genetic testing for dyslipidemia.
    Hertz CL; Christiansen SL; Ottesen GL; Frank-Hansen R; Bundgaard H; Morling N
    Int J Legal Med; 2016 Jul; 130(4):947-948. PubMed ID: 26490271
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview.
    Hutter CM; Austin MA; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):430-5. PubMed ID: 15321839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Kastelein JJ; Defesche JC
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of apoB mRNA editing in liver by gene-transfer as a potential approach for the treatment of severe forms of polygenic hypercholesterolemia--an outline of the rationale.
    Greeve J; Chowdhury JR
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():27-30. PubMed ID: 8767452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.